No. 3/ February 14, 2012

MDC Researchers Reveal Molecular Mechanism Underlying Severe Anomalies of the Forebrain

Development of the Forebrain

The dashed line marks the region of the neural tube out of which the forebrain develops. There in mouse embryos, a binding site (lipoprotein receptor LRP2) (green) for cholesterol is normally found (left image). This binding site plays a key role in the development of the forebrain. The signaling molecule sonic hedgehog (SHH) (red) arises from the structure marked with the arrow below the neural tube (prechordal plate) and accumulates in the overlying neural tube. Therefore a red signal is also visible in the forebrain structure. In mouse embryos in which the gene encoding LRP2 has been inactivated (right image), SHH is produced in the prechordal plate (arrow), but the signaling molecule does not accumulate in the overlying marked forebrain structure. The LRP2 receptor is lacking (no green signal). The researchers conclude that not only cholesterol is important for the activation and distribution of the signaling molecule SHH, but that also a lipoprotein receptor LRP2 is required in the target field to enhance the signal molecule. (Photo: Annabel Christ/ Copyright: MDC)

Researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch have now identified and described a molecular mechanism underlying the most common malformation of the brain in humans. In holoprosencephaly (HPE), the forebrain (prosencephalon) is only incompletely formed. Here a binding site (receptor) for cholesterol plays a key role. If this receptor is defective, specific signals cannot be received, and the forebrain cannot separate into two hemispheres, as Dr. Annabel Christ, Professor Thomas Willnow and Dr. Annette Hammes have now shown in mice (Developmental Cell, DOI 10.1016/j.devcel.2011.11.023)*.

Cholesterol has a bad reputation because it may lead to vascular calcification in adults (atherosclerosis) as well as to heart attacks and strokes. However, cholesterol is vital for embryonic development because it controls the development of the central nervous system. The lack of it can lead to severe developmental disorders of the forebrain (prosencephalon), the largest region of the human brain. One in 250 pregnancies does not come to term due to this malformation called holoprosencephaly (HPE). One in 16000 children is born with HPE, of which the mildest form is cleft lip and palate. In severe forms of HPE the affected children do not survive the first weeks of life.


HPE may be due to genetic factors, but environmental factors such as viral infections or alcohol abuse during pregnancy may also cause the malformation. Moreover, the cholesterol metabolism is also frequently disturbed. Thus, patients whose bodies cannot produce cholesterol due to a genetic disorder inevitably have HPE.


As Professor Willnow explained, the human brain develops from the neural tube, a simple tube-like cluster of cells in the embryo. Why defects in cholesterol metabolism lead to a developmental disorder of the neural tube and to HPE is thus far not completely understood. The studies of the Berlin researchers may give a possible clue. They identified a receptor called LRP2 that is formed in the neural tube and can bind lipoproteins, which are the transport form of cholesterol.


Interestingly, this receptor also binds an important signal molecule of forebrain development (sonic hedgehog, abbreviated SHH). As the researchers demonstrated, this lipoprotein receptor drives the accumulation of SHH in the neural tube at a specific site and induces the development of the forebrain structures. The researchers now suspect that cholesterol – directly or indirectly – plays a central role in controlling the activity of this novel receptor and assume that disturbances in cholesterol metabolism lead to a loss of function of this auxiliary receptor for SHH signaling.


*LRP2 Is an Auxiliary SHH Receptor Required to Condition the Forebrain Ventral Midline for Inductive Signals

Annabel Christ1, Anna Christa1, Esther Kur1, Oleg Lioubinski1, Sebastian Bachmann2, Thomas E. Willnow1,3* and Annette Hammes1,3

1Max Delbrück Center for Molecular Medicine

2Institute for Vegetative Anatomy Charité Universitätsmedizin, D-13125 Berlin, Germany

3These authors contributed equally to this work



Barbara Bachtler
Press Department
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch

in the Helmholtz Association
Robert-Rössle-Straße 10
13125 Berlin


Phone: +49 (0) 30 94 06 - 38 96
Fax:  +49 (0) 30 94 06 - 38 33



Images for download